Tag: NYSE:GSK

October 2, 2019

GlaxoSmithKline Files NDA for Inhaler to Treat Asthma

The company's inhaler therapy, Trelegy Ellipta, has already been approved in the US for chronic obstructive pulmonary disease.
September 10, 2019

VBI Vaccines Announces Phase 2a Clinical Evaluation of VBI-1901

VBI Vaccines (NASDAQ:VBI) has announced a collaboration with GlaxoSmithKline (NYSE:GSK) to evaluate VBI’s VBI-1901 with GSK’s AS01 adjuvant system. As...
August 29, 2019

AstraZeneca’s Lupus Drug Finally Meets Endpoints in Phase 3 Trial

The victory comes almost exactly a year after AstraZeneca's lupus treatment didn't meet its primary endpoints in a different trial.
August 28, 2019

10 Top Pharma Companies by Revenue

We break down the top pharma companies by revenue in 2018, according to information from research firm GlobalData.
August 15, 2019

10 Top Drug Sales to Watch Until 2024

Drug sales are expected to top US$1 trillion by 2024, even though a number of patents are set to expire...